{"id":1187,"date":"2026-10-16T10:00:00","date_gmt":"2026-10-16T10:00:00","guid":{"rendered":"https:\/\/medycyna-gorska.pl\/?p=1187"},"modified":"2026-10-16T10:02:29","modified_gmt":"2026-10-16T10:02:29","slug":"re-entry-hape-en","status":"publish","type":"post","link":"https:\/\/medycyna-gorska.pl\/en\/re-entry-hape-en\/","title":{"rendered":"Re-entry HAPE \u2014 pulmonary edema in altitude residents returning after absence"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Re-entry HAPE<\/strong> is a particular form of high-altitude pulmonary edema in people who live permanently at high altitude (La Paz 3600 m, Cuzco 3400 m, Leh 3500 m residents) and return after 2\u20136 weeks at low altitude. Mechanism: temporary loss of hypoxia tolerance makes return to home altitude trigger HAPE like in a non-acclimatized tourist. A phenomenon less known among trekkers but crucial for Sherpas, Peruvian guides, and Nepalese climatologists.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">In a nutshell \u2014 Re-entry HAPE<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Who:<\/strong> residents of altitude &gt;2500 m returning after &gt;2 weeks at &lt;1500 m<\/li>\n<li><strong>When:<\/strong> 24\u201372 h after returning to home altitude<\/li>\n<li><strong>Risk:<\/strong> 1\u20133% in children, &lt;0.5% in adults<\/li>\n<li><strong>Mechanism:<\/strong> loss of hypoxic pulmonary vasoconstriction (HPV) reaction and partial loss of polycythemia<\/li>\n<li><strong>Prophylaxis:<\/strong> nifedipine XL 30 mg 1\u00d7\/day for the first 5 days after return<\/li>\n<li><strong>Difference from classic HAPE:<\/strong> in an &#8220;autochthonous&#8221; person \u2014 already genetically and adaptively acclimatized<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Re-entry HAPE mechanism<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">1. Loss of HPV response (within weeks)<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Hypoxic pulmonary vasoconstriction (HPV) in altitude residents is gradually &#8220;trained&#8221; to a milder response. After moving to the lowlands (oxygen-rich), HPV fades within 1\u20133 weeks. Return to 3500 m triggers a strong, non-physiological HPV reaction \u2014 pulmonary arterial constriction, uneven perfusion, alveolar edema.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2. Loss of polycythemia<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">A La Paz resident typically has hematocrit 55\u201360% \u2014 better oxygen binding. After 2\u20134 weeks in the lowlands, hematocrit drops to 45\u201350%. Return to altitude = sudden tissue oxygen deficit, forced hemodynamic and ventilatory compensation.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3. Children particularly at risk<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Children 2\u201312 years old lose adaptation faster than adults (greater regulatory variability). After a lowland vacation, children from La Paz have 1\u20133% re-entry HAPE risk. Peruvian pediatrics has recommended nifedipine prophylaxis for children returning after a break for 30 years.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Prophylaxis \u2014 nifedipine protocol<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Nifedipine XL\/retard 30 mg<\/strong> 1\u00d7 daily morning<\/li>\n<li><strong>Start:<\/strong> 24 h before returning to altitude<\/li>\n<li><strong>Duration:<\/strong> 5 days after return (or until full readaptation)<\/li>\n<li><strong>Alternative:<\/strong> amlodipine 5\u201310 mg 1\u00d7 daily (longer half-life)<\/li>\n<li><strong>Salmeterol<\/strong> (inhaler 125 \u03bcg 2\u00d7 daily) \u2014 alternative or adjunct for patients with hypertension<\/li>\n<li><strong>Nifedipine side effects:<\/strong> initial headaches (2\u20133 days), ankle edema, facial flushing<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">I am not a great enthusiast of drug prophylaxis, because it gets overused \u2014 some climbers take these medicines like sweets. At base camp, though, I had a participant who acclimatized unusually slowly and had suffered high-altitude cerebral edema in the past. In his case the medication was justified and it worked: he acclimatized and continued the trek. That is the difference between prophylaxis based on a history of illness and prophylaxis just in case.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Who should consider prophylaxis<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sherpa returning after 3 weeks vacation<\/strong> in Kathmandu (1400 m) to trek with client from EBC (5364 m)<\/li>\n<li><strong>Andean guide<\/strong> returning after 1-month break<\/li>\n<li><strong>Children from autochthonous families<\/strong> La Paz \/ Potos\u00ed returning from coastal vacation<\/li>\n<li><strong>Cuzco physician<\/strong> returning after 2-week conference in Lima<\/li>\n<li><strong>People with HAPE-susceptible phenotype<\/strong> (prior HAPE episodes)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Symptoms and treatment<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Symptoms identical to classic HAPE: resting dyspnea, cough (later pink\/bloody), weakness, cyanosis, SpO\u2082 drops 10\u201315% below norm for altitude. Time of onset: 24\u201372 h after return. Treatment:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Oxygen<\/strong> (2\u20134 L\/min via mask) \u2014 most important first step<\/li>\n<li><strong>Immediate nifedipine 20 mg<\/strong> sublingual + 30 mg XL every 12 h<\/li>\n<li><strong>Sitting position<\/strong> (eases breathing)<\/li>\n<li><strong>Descent<\/strong> to 2000\u20132500 m if possible (rarely needed \u2014 re-entry HAPE responds well to oxygen + nifedipine)<\/li>\n<li><strong>Dexamethasone<\/strong> 4 mg every 6 h if accompanying HACE symptoms<\/li>\n<li><strong>Evacuation<\/strong> if no response in 2 h or SpO\u2082 &lt;70% with oxygen<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Frequently asked questions<\/h2>\n\n\n<div id=\"rank-math-faq\" class=\"rank-math-block\">\n<div class=\"rank-math-list \">\n<div id=\"faq-q-reentry-en-1\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">After how many weeks in lowlands does an altitude dweller lose acclimatization?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Evolutionary process: after 2 weeks in lowlands HPV (hypoxic pulmonary vasoconstriction) is already significantly &#8216;switched off&#8217;, after 4-6 weeks returns to values of a non-altitude-adapted person. Polycythemia (hematocrit) drops slower: 3-4% per week (from 58% to 50% in 4 weeks). Mitochondrial adaptation (muscle mitochondrial density) drops in 2-3 months. Conclusion: return after 6 weeks treat yourself as &#8216;outside&#8217; tourist.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-reentry-en-2\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Do I need nifedipine returning from Kathmandu vacation?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Depends on where you&#8217;re returning from and how long in lowlands. Sherpa returning from Kathmandu (1400 m) after 3 weeks to trek with client at EBC (5364 m) &#8211; yes, nifedipine XL 30 mg prophylaxis for 5 days is recommended. But Sherpa returning after 3 days lowland to trek in Namche (3440 m) &#8211; not necessary, altitude difference small, time short. Rule: difference &gt;2000 m altitude + stay &gt;2 weeks in lowlands = prophylaxis.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-reentry-en-3\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Can re-entry HAPE happen to an adult?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Yes, but more rarely than in children. Statistics: 0.3-0.5% adults returning to altitude after 2+ weeks vs 1-3% children 2-12 years. Men &gt;women (higher muscle mass = higher oxygen demand). Adult with prior HAPE (HAPE-susceptible) has re-entry risk of 5-15% &#8211; prophylaxis mandatory for them. Genetics: residents with ACE I\/I variant are more susceptible.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-reentry-en-4\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Is nifedipine XL available OTC in Peru\/Bolivia\/Nepal?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Yes, in high-altitude countries Andes and Himalayas nifedipine is available without prescription in pharmacies (paradoxically easier than in Europe\/USA). Peru: nifedipine XL 30 mg ~$10 per month course. Nepal: ~$8-12. Bolivia: ~$5-8. Note: check expiration and packaging integrity &#8211; some pharmacies keep old drugs in bad climate conditions. Better approach: bring from Europe\/USA as prophylaxis, buy locally only as rescue\/backup.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-reentry-en-5\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Salmeterol instead of nifedipine &#8211; when?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Salmeterol (inhaler 125 \u03bcg 2x\/day) is an alternative for patients who: 1) have controlled hypertension on beta-blocker (nifedipine may interfere); 2) have orthostatic hypotension (ankle edema and BP drop on nifedipine); 3) don&#8217;t tolerate oral prophylaxis (GI symptoms). Salmeterol acts directly in lungs, fewer systemic effects. Dose: 125 \u03bcg 2x\/day from return day for 5 days. Available in most countries without prescription. Cost: $30-50 per inhaler (small dose covers 3-4 courses).<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\">References<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hultgren HN, Marticorena EA. <em>High altitude pulmonary edema. Epidemiologic observations in Peru<\/em>. Chest. 1978;74(4):372\u2013376.<\/li>\n<li>B\u00e4rtsch P, Mairb\u00e4url H, Maggiorini M, Swenson ER. <em>Physiological aspects of high-altitude pulmonary edema<\/em>. J Appl Physiol. 2005;98(3):1101\u20131110.<\/li>\n<li>Scherrer U, Rexhaj E, Jayet PY, et al. <em>New insights in the pathogenesis of high-altitude pulmonary edema<\/em>. Prog Cardiovasc Dis. 2010;52(6):485\u2013492.<\/li>\n<li>Luks AM et al. <em>Wilderness Medical Society Clinical Practice Guidelines 2019<\/em>.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><em><strong>Note:<\/strong> Re-entry HAPE is particularly relevant for high-altitude residents (Sherpas, Andean guides) and their families. For typical trekkers less relevant, but important for understanding physiology. Consultation with mountain medicine physician recommended 2-4 weeks before returning to altitude.<\/em><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Re-entry HAPE in high-altitude residents returning from lowlands: mechanism, risk in children, nifedipine prophylaxis, treatment.<\/p>\n","protected":false},"author":2,"featured_media":1239,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-1187","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medycyna-gorska"],"_links":{"self":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts\/1187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/comments?post=1187"}],"version-history":[{"count":2,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts\/1187\/revisions"}],"predecessor-version":[{"id":1427,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts\/1187\/revisions\/1427"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/media\/1239"}],"wp:attachment":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/media?parent=1187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/categories?post=1187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/tags?post=1187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}